{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:24:11Z","timestamp":1792549451656,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82225026"],"award-info":[{"award-number":["82225026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["24ZXZSSS00200"],"award-info":[{"award-number":["24ZXZSSS00200"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["24JCZDJC00160"],"award-info":[{"award-number":["24JCZDJC00160"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1\u2013042"],"award-info":[{"award-number":["2021-I2M-1\u2013042"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2024-I2M-TS-026"],"award-info":[{"award-number":["2024-I2M-TS-026"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2022-I2M-2\u2013003"],"award-info":[{"award-number":["2022-I2M-2\u2013003"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74162-1","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:35:07Z","timestamp":1781307307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In situ reprogramming of CAR-alveolar macrophages via liposomal nanomedicine for lung cancer immunotherapy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4843-4361","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6022-9255","authenticated-orcid":false,"given":"Chaoyi","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3610-7874","authenticated-orcid":false,"given":"Xiaoyao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9334-8144","authenticated-orcid":false,"given":"Qian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7770-554X","authenticated-orcid":false,"given":"Yumin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0541-5072","authenticated-orcid":false,"given":"Jianfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"74162_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter, A., Veluswamy, R. R. & Wisnivesky, J. P. The global burden of lung cancer: current status and future trends. Nat. Rev. Clin. Oncol. 20, 624\u2013639 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"74162_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"74162_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","volume":"23","author":"G Oliveira","year":"2023","unstructured":"Oliveira, G. & Wu, C. J. Dynamics and specificities of T cells in cancer immunotherapy. Nat. Rev. Cancer 23, 295\u2013316 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"74162_CR4","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41571-025-01035-9","volume":"22","author":"S Zhao","year":"2025","unstructured":"Zhao, S., Zhao, H., Yang, W. & Zhang, L. The next generation of immunotherapies for lung cancers. Nat. Rev. Clin. Oncol. 22, 592\u2013616 (2025).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"74162_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cllc.2025.01.006","volume":"26","author":"WJ Phillips","year":"2025","unstructured":"Phillips, W. J. et al. Immunotherapy for early-stage non\u2013small cell lung cancer: a practical guide of current controversies. Clin. Lung Cancer 26, 179\u2013190 (2025).","journal-title":"Clin. Lung Cancer"},{"key":"74162_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00854-y","volume":"20","author":"A Naimi","year":"2022","unstructured":"Naimi, A. et al. Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell Commun. Signal. 20, 44 (2022).","journal-title":"Cell Commun. Signal."},{"key":"74162_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1126\/scitranslmed.abd1616","volume":"13","author":"A Martinez-Usatorre","year":"2021","unstructured":"Martinez-Usatorre, A. et al. Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models. Sci. Transl. Med. 13, 606 (2021).","journal-title":"Sci. Transl. Med."},{"key":"74162_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","volume":"41","author":"EN Arner","year":"2023","unstructured":"Arner, E. N. & Rathmell, J. C. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41, 421\u2013433 (2023).","journal-title":"Cancer Cell"},{"key":"74162_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li, K. et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct. Target. Ther. 6, 362 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"74162_CR10","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/scitranslmed.abo3605","volume":"14","author":"N Kirchhammer","year":"2022","unstructured":"Kirchhammer, N. et al. Combination cancer immunotherapies: emerging treatment strategies adapted to the tumor microenvironment. Sci. Transl. Med. 14, 670 (2022).","journal-title":"Sci. Transl. Med."},{"key":"74162_CR11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","volume":"186","author":"DJ Kloosterman","year":"2023","unstructured":"Kloosterman, D. J. & Akkari, L. Macrophages at the interface of the co-evolving cancer ecosystem. Cell 186, 1627\u20131651 (2023).","journal-title":"Cell"},{"key":"74162_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. & Allavena, P. Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399\u2013416 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"74162_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang, X., Wang, J., Lu, D. & Xu, X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct. Target. Ther. 6, 75 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"74162_CR14","first-page":"359","volume":"16","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Polarization of tumor-associated macrophages by TLR7\/8 conjugated radiosensitive peptide hydrogel for overcoming tumor radioresistance. Bioact. Mater. 16, 359\u2013371 (2022).","journal-title":"Bioact. Mater."},{"key":"74162_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41577-023-00848-y","volume":"23","author":"E Mass","year":"2023","unstructured":"Mass, E., Nimmerjahn, F., Kierdorf, K. & Schlitzer, A. Tissue-specific macrophages: how they develop and choreograph tissue biology. Nat. Rev. Immunol. 23, 563\u2013579 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"74162_CR16","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.immuni.2022.08.010","volume":"55","author":"H Aegerter","year":"2022","unstructured":"Aegerter, H., Lambrecht, B. N. & Jakubzick, C. V. Biology of lung macrophages in health and disease. Immunity 55, 1564\u20131580 (2022).","journal-title":"Immunity"},{"key":"74162_CR17","doi-asserted-by":"publisher","first-page":"111828","DOI":"10.1016\/j.celrep.2022.111828","volume":"41","author":"T Kawasaki","year":"2022","unstructured":"Kawasaki, T. et al. Alveolar macrophages instruct CD8+ T cell expansion by antigen cross-presentation in lung. Cell Rep. 41, 111828 (2022).","journal-title":"Cell Rep."},{"key":"74162_CR18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","volume":"595","author":"M Casanova-Acebes","year":"2021","unstructured":"Casanova-Acebes, M. et al. Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells. Nature 595, 578\u2013584 (2021).","journal-title":"Nature"},{"key":"74162_CR19","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.ccell.2023.05.006","volume":"41","author":"LI Prieto","year":"2023","unstructured":"Prieto, L. I. et al. Senescent alveolar macrophages promote early-stage lung tumorigenesis. Cancer Cell 41, 1261\u20131275 (2023).","journal-title":"Cancer Cell"},{"key":"74162_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35701-8","volume":"14","author":"S Taniguchi","year":"2023","unstructured":"Taniguchi, S. et al. In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma. Nat. Commun. 14, 143 (2023).","journal-title":"Nat. Commun."},{"key":"74162_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41590-023-01428-x","volume":"24","author":"T Wang","year":"2023","unstructured":"Wang, T. et al. Influenza-trained mucosal-resident alveolar macrophages confer long-term antitumor immunity in the lungs. Nat. Immunol. 24, 423\u2013438 (2023).","journal-title":"Nat. Immunol."},{"key":"74162_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120579","volume":"268","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Polymer-lipid hybrid nanovesicle-enabled combination of immunogenic chemotherapy and RNAi-mediated PD-L1 knockdown elicits antitumor immunity against melanoma. Biomaterials 268, 120579 (2021).","journal-title":"Biomaterials"},{"key":"74162_CR23","first-page":"3924","volume":"6","author":"Q Su","year":"2021","unstructured":"Su, Q. et al. Supramolecular co-assembly of self-adjuvanting nanofibrious peptide hydrogel enhances cancer vaccination by activating MyD88-dependent NF-\u03baB signaling pathway without inflammation. Bioact. Mater. 6, 3924\u20133934 (2021).","journal-title":"Bioact. Mater."},{"key":"74162_CR24","doi-asserted-by":"publisher","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","volume":"176","author":"DE Large","year":"2021","unstructured":"Large, D. E., Abdelmessih, R. G., Fink, E. A. & Auguste, D. T. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv. Drug Deliv. Rev. 176, 113851 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"74162_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202400307","volume":"36","author":"S Xu","year":"2024","unstructured":"Xu, S. et al. Tumor-tailored ionizable lipid nanoparticles facilitate IL-12 circular RNA delivery for enhanced lung cancer immunotherapy. Adv. Mater. 36, e2400307 (2024).","journal-title":"Adv. Mater."},{"key":"74162_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/imr.13273","volume":"320","author":"MN Kronig","year":"2023","unstructured":"Kronig, M. N., Wehrli, M., Salas-Benito, D. & Maus, M. V. Hurdles race for CAR T-cell therapy in digestive tract cancer. Immunol. Rev. 320, 100\u2013119 (2023).","journal-title":"Immunol. Rev."},{"key":"74162_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41590-022-01146-w","volume":"23","author":"S Subramanian","year":"2022","unstructured":"Subramanian, S. et al. Long-term culture-expanded alveolar macrophages restore their full epigenetic identity after transfer in vivo. Nat. Immunol. 23, 458\u2013468 (2022).","journal-title":"Nat. Immunol."},{"key":"74162_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts, D. et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat. Med. 24, 1277\u20131289 (2018).","journal-title":"Nat. Med."},{"key":"74162_CR29","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1021\/acsnano.3c12387","volume":"18","author":"SL Li","year":"2024","unstructured":"Li, S. L. et al. Nanomaterials-involved tumor-associated macrophages\u2019 reprogramming for antitumor therapy. ACS Nano 18, 7769\u20137795 (2024).","journal-title":"ACS Nano"},{"key":"74162_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","volume":"25","author":"A Lei","year":"2024","unstructured":"Lei, A. et al. A second-generation M1-polarized CAR macrophage with antitumor efficacy. Nat. Immunol. 25, 102\u2013116 (2024).","journal-title":"Nat. Immunol."},{"key":"74162_CR31","doi-asserted-by":"publisher","first-page":"111605","DOI":"10.1016\/j.biopha.2021.111605","volume":"139","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. CAR-macrophage: a new immunotherapy candidate against solid tumors. Biomed. Pharmacother. 139, 111605 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"74162_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ccell.2023.03.019","volume":"41","author":"CE Weeden","year":"2023","unstructured":"Weeden, C. E. et al. Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer. Cancer Cell 41, 837\u2013852.e836 (2023).","journal-title":"Cancer Cell"},{"key":"74162_CR33","doi-asserted-by":"crossref","unstructured":"Lavin, Y., Mortha, A., Rahman, A. & Merad, M. Regulation of macrophage development and function in peripheral tissues. Nat. Rev. Immunol. 15, 731\u2013744 (2015).","DOI":"10.1038\/nri3920"},{"key":"74162_CR34","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/cac2.12345","volume":"42","author":"K Cheng","year":"2022","unstructured":"Cheng, K. et al. Tumor-associated macrophages in liver cancer: from mechanisms to therapy. Cancer Commun. 42, 1112\u20131140 (2022).","journal-title":"Cancer Commun."},{"key":"74162_CR35","doi-asserted-by":"publisher","first-page":"113845","DOI":"10.1016\/j.jconrel.2025.113845","volume":"383","author":"J Yang","year":"2025","unstructured":"Yang, J., Zeng, Z., Liu, Y., Li, Y. & Xu, X. Developing bioinspired delivery systems for enhanced tumor penetration of macromolecular drugs. J. Control. Release 383, 113845 (2025).","journal-title":"J. Control. Release"},{"key":"74162_CR36","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"A Raguram","year":"2022","unstructured":"Raguram, A., Banskota, S. & Liu, D. R. Therapeutic in vivo delivery of gene editing agents. Cell 185, 2806\u20132827 (2022).","journal-title":"Cell"},{"key":"74162_CR37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.ade6967","volume":"381","author":"L Breda","year":"2023","unstructured":"Breda, L. et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science 381, 436\u2013443 (2023).","journal-title":"Science"},{"key":"74162_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113888","volume":"384","author":"W Wang","year":"2025","unstructured":"Wang, W. et al. In vivo FAP-CAR macrophages enhance chemotherapy and immunotherapy against pancreatic cancer by removing the fibrosis barrier. J. Control. Release 384, 113888 (2025).","journal-title":"J. Control. Release"},{"key":"74162_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59489-5","volume":"16","author":"G Son","year":"2025","unstructured":"Son, G. et al. Fusogenic lipid nanoparticles for rapid delivery of large therapeutic molecules to exosomes. Nat. Commun. 16, 4799 (2025).","journal-title":"Nat. Commun."},{"key":"74162_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46533-z","volume":"15","author":"H Kong","year":"2024","unstructured":"Kong, H. et al. An antifouling membrane-fusogenic liposome for effective intracellular delivery in vivo. Nat. Commun. 15, 4267 (2024).","journal-title":"Nat. Commun."},{"key":"74162_CR41","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1038\/s41375-021-01287-1","volume":"35","author":"A Stoll","year":"2021","unstructured":"Stoll, A. et al. CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes\/macrophages enhancing their tumoricidal activity. Leukemia 35, 3482\u20133496 (2021).","journal-title":"Leukemia"},{"key":"74162_CR42","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky, M. et al. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat. Biotechnol. 38, 947\u2013953 (2020).","journal-title":"Nat. Biotechnol."},{"key":"74162_CR43","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s43018-025-00950-1","volume":"6","author":"W Jing","year":"2025","unstructured":"Jing, W. et al. An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma. Nat. Cancer 6, 838\u2013853 (2025).","journal-title":"Nat. Cancer"},{"key":"74162_CR44","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jtho.2024.03.019","volume":"19","author":"LY Hu","year":"2024","unstructured":"Hu, L. Y. et al. EGFR oncogenic mutations in NSCLC impair macrophage phagocytosis and mediate innate immune evasion through up-regulation of CD47. J. Thorac. Oncol. 19, 1186\u20131200 (2024).","journal-title":"J. Thorac. Oncol."},{"key":"74162_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20240027","volume":"4","author":"M Li","year":"2024","unstructured":"Li, M. et al. Bioengineer mesenchymal stem cell for treatment of glioma by IL-12 mediated microenvironment reprogramming and nCD47-SLAMF7 mediated phagocytosis regulation of macrophages. Exploration 4, 20240027 (2024).","journal-title":"Exploration"},{"key":"74162_CR46","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D. et al. SRplot: a free online platform for data visualization and graphing. PLoS ONE 18, e0294236 (2023).","journal-title":"PLoS ONE"},{"key":"74162_CR47","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genomics Proteom. Bioinforma. 19, 578\u2013583 (2021).","journal-title":"Genomics Proteom. Bioinforma."},{"key":"74162_CR48","doi-asserted-by":"publisher","first-page":"D28","DOI":"10.1093\/nar\/gkaf1172","volume":"54","author":"CNCB-NGDC Members and Partners","year":"2026","unstructured":"CNCB-NGDC Members and Partners Database resources of the national genomics data center, China National Center for Bioinformation in 2026. Nucleic Acids Res. 54, D28\u2013D47 (2026).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74162-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74162-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74162-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:14:31Z","timestamp":1785518071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74162-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74162"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74162-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7495"}}